Gilead Sciences Inc
LSE:0QYQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
LSE:0QYQ
|
US |
|
M
|
Manulife Financial Corp
HKEX:945
|
CA |
|
A
|
Adobe Inc
SWB:ADB
|
US |
|
China Life Insurance Co Ltd
SSE:601628
|
CN |
|
Great Elm Capital Corp
NASDAQ:GECC
|
US |
|
L
|
L & K Engineering Co Ltd
TWSE:6139
|
TW |
|
Sumitomo Realty & Development Co Ltd
TSE:8830
|
JP |
|
N
|
Nov Inc
F:NO8
|
US |
|
A
|
Advanced Micro Devices Inc
F:AMD
|
US |
|
M
|
Manulife Financial Corp
LSE:0V5H
|
CA |
|
O
|
Osaka Gas Co Ltd
XBER:OSA
|
JP |
|
L
|
Lineage Cell Therapeutics Inc
AMEX:LCTX
|
US |
|
I
|
ITV PLC
SWB:IJ7
|
UK |
|
B
|
BWX Technologies Inc
XBER:4BW
|
US |
|
Meituan
HKEX:3690
|
CN |
|
Shiseido Co Ltd
OTC:SSDOY
|
JP |
Wall St Price Targets
0QYQ Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for 0QYQ is 161.75 USD with a low forecast of 123.27 USD and a high forecast of 189.08 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QYQ's stock price target?
Price Target
161.75
USD
According to Wall Street analysts, the average 1-year price target for 0QYQ is 161.75 USD with a low forecast of 123.27 USD and a high forecast of 189.08 USD.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.
